Nurix Therapeutics, Inc. NRIX Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s convertible preferred stock authorized shares?
- Nurix Therapeutics, Inc. (NRIX) reported convertible preferred stock authorized shares of 10M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s convertible preferred stock authorized shares changed year-over-year?
- Nurix Therapeutics, Inc.'s convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 10M to 10M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s convertible preferred stock authorized shares?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.